ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $130 | +54.8% | 4,782 | +75.9% | 0.00% | 0.0% |
Q2 2023 | $84 | +12.0% | 2,718 | +30.7% | 0.00% | 0.0% |
Q1 2023 | $75 | +23.0% | 2,080 | +33.8% | 0.00% | – |
Q4 2022 | $61 | -99.9% | 1,554 | -15.5% | 0.00% | -100.0% |
Q3 2022 | $74,000 | -22.1% | 1,839 | -18.5% | 0.00% | 0.0% |
Q2 2022 | $95,000 | -65.2% | 2,257 | -67.8% | 0.00% | -50.0% |
Q1 2022 | $273,000 | +58.7% | 7,002 | +62.0% | 0.00% | +100.0% |
Q4 2021 | $172,000 | +17100.0% | 4,322 | +28713.3% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | – | 15 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |